(Q44574458)

4 December 2017

title

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy (English)

1 reference

4 December 2017

1 reference

1 reference

William C Lavely

1

1 reference

4 December 2017

Dominique Delbeke

2

1 reference

4 December 2017

John P Greer

3

1 reference

4 December 2017

David S Morgan

4

1 reference

4 December 2017

Daniel W Byrne

5

1 reference

4 December 2017

Ronald R Price

6

1 reference

4 December 2017

Dennis E Hallahan

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

International Journal of Radiation Oncology Biology Physics

4 December 2017

published in

1 reference

4 December 2017

volume

57

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

307-315

1 reference

Positron emission tomography imaging in oncology

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

State of the art in emission tomography equipment.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Spiral interpolation algorithm for multislice spiral CT--part I: theory.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900599-6

7 January 2021

10.1016/S0360-3016(03)00599-6

Identifiers

DOI

1 reference

4 December 2017

1 reference